Eduardo Ekman Schenberg
Datos Biográficos
| ID | 132469 |
|---|---|
| NOMBRE | Eduardo Ekman Schenberg |
| NOMBRES | Eduardo Ekman |
| APELLIDO | Schenberg |
| FIRMA | SCHENBERG E E |
| AFILIACIONES | Instituto Phaneros |
| ORCID | 0000-0001-7111-9891 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 7 |
| TOTAL DE CITAS | 10 |
| TOTAL COMO AUTOR | 7 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2017 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 2 |
Whose Hope? Power, knowledge, and the decolonization of psychedelic ethics
The global expansion of psychedelic research, clinical translation, and policy reform has intensified debates concerning safety, equity, cultural appropriation, and Indigenous rights. A prominent contribution to these discussions is the Hopkins–Oxford Psychedelic Ethics (HOPE) Consensus Statement (Jacobs et al., 2024), which proposes a foundational ethical framework for a field undergoing rapid institutionalization. HOPE advances important commit…
Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation
Epistemic losses, cultural exclusions, and the risk of biopiracy in the globalization of ayahuasca
The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness
This study sought to investigate the effects of different substances on nature relatedness (NR) in the general population. An online cross-sectional survey done in Brazil investigated use of ayahuasca/DMT, psilocybe mushrooms, LSD, MDMA/ecstasy, cocaine, cannabis, and alcohol. NR was assessed using the short-form version of the nature related scale (NR-6). One-way analysis of variance (ANOVA) was used to assess group differences between substance…
Overcoming epistemic injustices in the biomedical study of ayahuasca
After decades of biomedical research on ayahuasca's molecular compounds and their physiological effects, recent clinical trials show evidence of therapeutic potential for depression. However, indigenous peoples have been using ayahuasca therapeutically for a very long time, and thus we question the epistemic authority attributed to scientific studies, proposing that epistemic injustices were committed with practical, cultural, social, and legal c…
Treating drug dependence with the aid of ibogaine
Substance use disorders are important contributors to the global burden of disease, but current treatments are not associated with high rates of recovery. The lack of approved and effective treatments is acutely problematic for psychostimulants like cocaine and crack cocaine. One promising alternative in the treatment of drug dependence in general and psychostimulants in particular is the use of the psychedelic alkaloid ibogaine combined with psy…
A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment
Objective This report documents the phenomenology of the subjective experiences of 22 patients with substance-related disorders who were involved in a treatment combining cognitive–behavioral therapy and hospital sessions with ibogaine in Brazil. Methods Participants underwent a one-to-one semi-structured interview exploring the subjective effects of ibogaine. We employed interpretative phenomenological analysis to identify relevant phenomenologi…
Treating drug dependence with the aid of ibogaine
Substance use disorders are important contributors to the global burden of disease, but current treatments are not associated with high rates of recovery. The lack of approved and effective treatments is acutely problematic for psychostimulants like cocaine and crack cocaine. One promising alternative in the treatment of drug dependence in general and psychostimulants in particular is the use of the psychedelic alkaloid ibogaine combined with psy…
A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment
Objective This report documents the phenomenology of the subjective experiences of 22 patients with substance-related disorders who were involved in a treatment combining cognitive–behavioral therapy and hospital sessions with ibogaine in Brazil. Methods Participants underwent a one-to-one semi-structured interview exploring the subjective effects of ibogaine. We employed interpretative phenomenological analysis to identify relevant phenomenologi…
Overcoming epistemic injustices in the biomedical study of ayahuasca
After decades of biomedical research on ayahuasca's molecular compounds and their physiological effects, recent clinical trials show evidence of therapeutic potential for depression. However, indigenous peoples have been using ayahuasca therapeutically for a very long time, and thus we question the epistemic authority attributed to scientific studies, proposing that epistemic injustices were committed with practical, cultural, social, and legal c…
Treating drug dependence with the aid of ibogaine
Substance use disorders are important contributors to the global burden of disease, but current treatments are not associated with high rates of recovery. The lack of approved and effective treatments is acutely problematic for psychostimulants like cocaine and crack cocaine. One promising alternative in the treatment of drug dependence in general and psychostimulants in particular is the use of the psychedelic alkaloid ibogaine combined with psy…
A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment
Objective This report documents the phenomenology of the subjective experiences of 22 patients with substance-related disorders who were involved in a treatment combining cognitive–behavioral therapy and hospital sessions with ibogaine in Brazil. Methods Participants underwent a one-to-one semi-structured interview exploring the subjective effects of ibogaine. We employed interpretative phenomenological analysis to identify relevant phenomenologi…
Epistemic losses, cultural exclusions, and the risk of biopiracy in the globalization of ayahuasca
The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness
This study sought to investigate the effects of different substances on nature relatedness (NR) in the general population. An online cross-sectional survey done in Brazil investigated use of ayahuasca/DMT, psilocybe mushrooms, LSD, MDMA/ecstasy, cocaine, cannabis, and alcohol. NR was assessed using the short-form version of the nature related scale (NR-6). One-way analysis of variance (ANOVA) was used to assess group differences between substance…
Overcoming epistemic injustices in the biomedical study of ayahuasca
After decades of biomedical research on ayahuasca's molecular compounds and their physiological effects, recent clinical trials show evidence of therapeutic potential for depression. However, indigenous peoples have been using ayahuasca therapeutically for a very long time, and thus we question the epistemic authority attributed to scientific studies, proposing that epistemic injustices were committed with practical, cultural, social, and legal c…
Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation
Whose Hope? Power, knowledge, and the decolonization of psychedelic ethics
The global expansion of psychedelic research, clinical translation, and policy reform has intensified debates concerning safety, equity, cultural appropriation, and Indigenous rights. A prominent contribution to these discussions is the Hopkins–Oxford Psychedelic Ethics (HOPE) Consensus Statement (Jacobs et al., 2024), which proposes a foundational ethical framework for a field undergoing rapid institutionalization. HOPE advances important commit…
Psychedelics and Drug Studies (7 obras) · Ayahuasca (5 obras) · Medicine (5 obras) · Psychology (5 obras) · Biochemical Analysis and Sensing Techniques (4 obras) · Psychiatry (4 obras) · Clinical Psychology (3 obras) · Hallucinogen (3 obras) · Neurotransmitter Receptor Influence on Behavior (3 obras) · Psychotherapist (3 obras)